CD8A and neoplasm: Treg cells can inhibit the proliferation and efficacy of CD8+ T cells, which is considered to be one of the major obstacles to successful clinical application of tumor immunotherapy (Poehlein et al. 2009; Arce Vargas et al. 2017).